Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas

Archives of Dermatology

Volumn 145, Issue 3, 2009, Pages 262-266

  Lomenick, Jefferson P ^a,b   Reifschneider, Kent L ^a   Lucky, Anne W ^a   Adams, Denise ^a   Azizkhan, Richard G ^a   Woo, Jessica G ^a   Backeljauw, Philippe F ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE; TETRACOSACTIDE;

ADRENAL INSUFFICIENCY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CORTICOTROPIN TEST; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEMANGIOMA; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFANT; LOW DRUG DOSE; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT;

ADRENAL INSUFFICIENCY; COSYNTROPIN; FEMALE; GLUCOCORTICOIDS; HEMANGIOMA; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFANT; MALE; PITUITARY-ADRENAL SYSTEM; PREDNISOLONE; SKIN NEOPLASMS;

EID: 62649143520     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2008.572     Document Type: Article

References (23)

1. Darmstadt GL, Sidbury R. Vascular disorders. In: Behrman RE. Kliegman RM, Jenson HB, eds. Nelson textbook of pediatrics. 17th ed. Philadelphia, PA: Saunders; 2004:2187-2172.
2. Frieden IJ. Eichenfield LF, Esterly NB, Geronemus R, Mallory SB; American Academy of Dermatology Guidelines/Outcomes Committee. Guidelines of carefor hemangiomas of infancy. J Am Acad Dermatol. 1997;37(4):831-637.
3. Bennett ML, Fleischer AB Jr. Chamlin SL. Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol. 2001:137(9) 1208-1213.
4. Williams EF III, Stan is I aw P, Dupree M, Mourtzikos K, Mihm M, Shannon L. Hemangiomas in infants and children: an algorithm for intervention. Arch Facial PlastSurg. 2000:2(2)103-111.
5. Akyüz C. Yaris N. Kutluk MT. Buyukpamukcu M. Management of cutaneous hem-angiomas: a retrospective analysis of 1109 cases and comparison of conventional dose prednisolone with high-dose methylprednisolone therapy. Pediatr Hematol Onco/. 2001;18(1):47-55.
6. Orth DM. Kovacs WJ. The adrenal cortex. In: Wilson JD, Foster DW, Kronen berg HM, eds. Williams Textbook of Endocrinology. 9th ed. Philadelphia, PA: WB Saunders: 1998:517-664.
7. Henzen C, Sliter A, Lerch E, Urbinelli R, Schorno XH, Briner VA. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet 2000;355(9203):542-545.
8. Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin- releasing hormone. N Engl J Med. 1992;328(4):226-230.
9. GraberAL, Ney RL, Nicholson WE, Island DP, Liddle GW, Natural history of pituitary- ad renal recovery following long-term suppression with corticosteroids. J Clin Endocrinol Metab. 1965:25:11-16.
10. Wilson KS, Parker AC. Adrenal suppression after short-term corticosteroid therapy [letter]. Lancet. 1979:1(8124)1030,
11. Livanou T, Ferriman D, James VH. Recovery of hypothalamo-pituitary- adrenal function after corticosteroid therapy. Lancet 1967;2(75211:856-859.
12. George ME, Sharma V, Jacobson J, Simon S, Nopper AJ. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol. 2004;140(8):963-969.
13. Pope E, Krafchik BR, Macarthur C, et al. Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics. 2007:119(6):e1239-e1247.
14. Lomenick JP, Backeljauw PF, Lucky AW. Growth, bone mineral accretion, and adrenal function in gIucocorticoid-treated infants with hemangiomas-a retrospective study. Pediatr Dermatol. 2006:23(2):189-174.
15. Rose SR, Lustig RH, Burstein S, Pitukcheewanont P. Broome DC, Burghen GA. Diagnosis of ACTH deficiency: comparison of overnight metyrapone test to either low-dose or high-dose ACTH test. Horm Res. 1999;52(2):73-79.
16. Dickstein G, Arad E, Shechner C. Low-dose ACTH stimulation test. Endocrinologist. 1997;7:285-293.
17. Miller WL. The adrenal cortex. In: Sperling MA, ed. Pediatric Endocrinology. 2nd ed, Philadelphia: WB Saunders; 2002:385-438.
18. Agwu JC, Spoudeas H, Hindmarsh PC, Pringle PJ, Brook CG. Tests of adrenal insufficiency. Arch Dis Child. 1999;80(4):330-333.
19. Tordjman K, Jaffe A, Grazas N, Apter C, Stern N. The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases, J Clin Endocrinol Metab. 1995;80(4) :1301-1305.
20. Broide J, Soferman R, Kivity S, etal. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids, J Clin Endocrinol Metab. 1995;80(4):1243-1246.
21. Rasmuson S, Olsson T, Hagg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis, Clin Endocrinol (Oxf). 1996;44(2): 151-156.
22. Gone EN, Kandemir N, Kinik ST. Significance of low-dose and standard-dose ACTH tests compared to overnight metyrapone test in the diagnosis of adrenal insufficiency in childhood. Norm Res. 2003;8D(4):191-197.
23. LomenickJP, Smith WJ. Low-dose adrenocorticotropic hormone stimulation testing in term infants. J Pediatr Endocrinol Metab. 2007;20(7):773-779.